|
Monday, February 13 2012 |
|
Acasti Pharma Closes $2,000,000 CDN Private Placement
|
|
Tuesday, February 07 2012 |
|
Acasti Pharma Announces a Private Placement Financing of Approximately $2,000,000 CDN
|
|
Tuesday, January 17 2012 |
|
Acasti Pharma Reports Third Quarter Results
|
|
Monday, January 09 2012 |
|
Acasti Pharma to Present at OneMedForum Conference
|
|
Wednesday, December 07 2011 |
|
Acasti Pharma to Present at The American Academy of Anti-Aging Medicine (A4M) and to
The American Academy of Private Physicians
|
|
Monday, December 05 2011 |
|
Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of its IP Position
|
|
Monday, October 17 2011 |
|
Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial
|
|
Friday, October 14 2011 |
|
Acasti Pharma Reports Second Quarter Results
|
|
Tuesday, October 04 2011 |
|
Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre® for the treatment of Hypertriglyceridemia
|
|
Wednesday, September 21 2011 |
|
Acasti Pharma to Present at JMP Healthcare Conference
|
